Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- Yellow powder
- Identity
- 1H-NMR
Properties
- Solvents
- DMSO (10 mg/ml), ethanol (5 mg/ml)
Available from stock
Ethionamide
- SKU
- E0237
Category: Amino Acids, Peptides, Proteins
- Synonyms
- ETA , ETH , 2-Ethyl-4-pyridinecarbothioamide , NSC 255115 , Trecator
- 536-33-4
- CAS-Number
- C8H10N2S
- Molecular Formula
- 166.24
- Molecular Weight
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
- Shipping
- AMBIENT
- Short Term Storage
- RT
- Long Term Storage
- +4°C
- Handling Advice
- Protect from light and moisture.
- Use / Stability
- Stable for at least 2 years after receipt when stored at +4°C.
- Hazard statements
- H302-H361
- Precautionary statements
- P281
- GHS Symbol
- GHS07+GHS08
- Signal word
- Warning
- Transportation
- Not dangerous goods
- Description
- Ethionamide is an antimycobacterial antibiotic that is active against M. tuberculosis (MICs = 0.3-1.25 µg/ml). Ethionamide is a prodrug activated via oxidation by ethA (a flavin monooxygenase) and leading to the formation of an soxide metabolite, which inhibits the InhA enzyme involved in mycolic acid biosynthesis. Formulations containing ethionamide have been used in the second-line treatment of multi-drug resistant tuberculosis. Ethionamide inhibits both biofilm formation and viability of mature biofilms. Ethionamide is a thioamide analog of the first-line tuberculosis drug isoniazid.
- Smiles
- NC(C1=CC(CC)=NC=C1)=S
- InChi Key
- AEOCXXJPGCBFJA-UHFFFAOYSA-N
- References
- (1) L.B. Heifets, et al., Am. Rev. Respir. Dis. 143, 268 (1991) , (2) T.A. Vannelli, et al., J. Biol. Chem. 277, 12824 (2002) , (3) K.A. Wolff & L. Nguyen, Expert Rev. Anti Infect. Ther. 10, 971 (2012) (Review) , (4) N. Vale, et al., Curr. Drug Metab. 14, 151 (2013) (Review) , (5) J. Laborde, et al., Chem. Med. Chem. 12, 1657 (2017)
- InChi
- InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)
Ethionamide is an antimycobacterial antibiotic that is active against M. tuberculosis (MICs = 0.3-1.25 µg/ml). Ethionamide is a prodrug activated via oxidation by ethA (a flavin monooxygenase) and leading to the formation of an soxide metabolite, which inhibits the InhA enzyme involved in mycolic acid biosynthesis. Formulations containing ethionamide have been used in the second-line treatment of multi-drug resistant tuberculosis. Ethionamide inhibits both biofilm formation and viability of mature biofilms. Ethionamide is a thioamide analog of the first-line tuberculosis drug isoniazid.
Zusätzliche Informationen
| Synonyms | ETA, ETH, 2-Ethyl-4-pyridinecarbothioamide, NSC 255115, Trecator |
|---|---|
| Purity | ≥98% (HPLC) |
| Appearance | Yellow powder |
| CAS-Number | 536-33-4 |
| Molecular Formula | C8H10N2S |
| Molecular Weight | 166.24 |
| Identity | 1H-NMR |
| Solvents | DMSO (10 mg/ml), ethanol (5 mg/ml) |
| Smiles | NC(C1=CC(CC)=NC=C1)=S |
| InChi Key | AEOCXXJPGCBFJA-UHFFFAOYSA-N |
| Shipping | AMBIENT |
| Short Term Storage | RT |
| Long Term Storage | +4°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Hazard statements | H302-H361 |
| Precautionary statements | P281 |
| GHS Symbol | GHS07+GHS08 |
| Signal word | Warning |
| Transportation | Not dangerous goods |
| References | (1) L.B. Heifets, et al., Am. Rev. Respir. Dis. 143, 268 (1991), (2) T.A. Vannelli, et al., J. Biol. Chem. 277, 12824 (2002), (3) K.A. Wolff & L. Nguyen, Expert Rev. Anti Infect. Ther. 10, 971 (2012) (Review), (4) N. Vale, et al., Curr. Drug Metab. 14, 151 (2013) (Review), (5) J. Laborde, et al., Chem. Med. Chem. 12, 1657 (2017) |
| InChi | InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11) |
| Quantity | 5 g, 25 g, 100 g, Bulk |
